If you operate a 503A compounding pharmacy, preparing for an FDA inspection is not the same as preparing a conventional pharmaceutical manufacturing facility for a CGMP inspection. Drugs compounded in accordance with the conditions of Section 503A may qualify for exemptions from certain provisions of the Federal Food, Drug, and Cosmetic Act, including federal current

Vince Sebald
September 15, 2026

If you operate a 503A compounding pharmacy, you may not be required to use validated software in the same way as a pharmaceutical manufacturer or a 503B outsourcing facility. But that does not necessarily mean that non-validated software is the better choice. When validated software is available at a similar cost, is straightforward to implement,

Vince Sebald
August 21, 2026